These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
196 related articles for article (PubMed ID: 31059393)
21. US LI-RADS Visualization Score: Interobserver Variability and Association With Cause of Liver Disease, Sex, and Body Mass Index. Kiri L; Abdolell M; Costa AF; Keough V; Rowe J; Butt R; Clarke SE Can Assoc Radiol J; 2022 Feb; 73(1):68-74. PubMed ID: 33938768 [TBL] [Abstract][Full Text] [Related]
22. US LI-RADS in surveillance for recurrent hepatocellular carcinoma after curative treatment. Huang H; Cheng MQ; He DN; Xian MF; Zeng D; Wu SH; Li CQ; Ruan SM; Li MD; Lin MX; Lu MD; Kuang M; Wang W; Chen LD Eur Radiol; 2023 Dec; 33(12):9357-9367. PubMed ID: 37460801 [TBL] [Abstract][Full Text] [Related]
23. Diagnostic performance of MR for hepatocellular carcinoma based on LI-RADS v2018, compared with v2017. Ren AH; Zhao PF; Yang DW; Du JB; Wang ZC; Yang ZH J Magn Reson Imaging; 2019 Sep; 50(3):746-755. PubMed ID: 30648327 [TBL] [Abstract][Full Text] [Related]
24. Accuracy of the Liver Imaging Reporting and Data System in Computed Tomography and Magnetic Resonance Image Analysis of Hepatocellular Carcinoma or Overall Malignancy-A Systematic Review. van der Pol CB; Lim CS; Sirlin CB; McGrath TA; Salameh JP; Bashir MR; Tang A; Singal AG; Costa AF; Fowler K; McInnes MDF Gastroenterology; 2019 Mar; 156(4):976-986. PubMed ID: 30445016 [TBL] [Abstract][Full Text] [Related]
25. Update on the Liver Imaging Reporting and Data System: What the Pathologist Needs to Know. Tang A; Valasek MA; Sirlin CB Adv Anat Pathol; 2015 Sep; 22(5):314-22. PubMed ID: 26262514 [TBL] [Abstract][Full Text] [Related]
26. LI-RADS Version 2017 versus Version 2018: Diagnosis of Hepatocellular Carcinoma on Gadoxetate Disodium-enhanced MRI. Lee SM; Lee JM; Ahn SJ; Kang HJ; Yang HK; Yoon JH Radiology; 2019 Sep; 292(3):655-663. PubMed ID: 31310175 [TBL] [Abstract][Full Text] [Related]
27. MR versus CEUS LI-RADS for Distinguishing Hepatocellular Carcinoma from other Hepatic Malignancies in High-Risk Patients. Huang Z; Zhou P; Li S; Li K Ultrasound Med Biol; 2021 May; 47(5):1244-1252. PubMed ID: 33610338 [TBL] [Abstract][Full Text] [Related]
29. Effectiveness of US Surveillance of Hepatocellular Carcinoma in Chronic Hepatitis B: US LI-RADS Visualization Score. Park MK; Lee DH; Hur BY; Lee HC; Lee YB; Yu SJ; Kim YJ; Yoon JH; Lee JH Radiology; 2023 Jun; 307(5):e222106. PubMed ID: 37249427 [TBL] [Abstract][Full Text] [Related]
30. Ultrasound Liver Imaging Reporting and Data System (US LI-RADS) Visualization Score: a reliability analysis on inter-reader agreement. Tiyarattanachai T; Bird KN; Lo EC; Mariano AT; Ho AA; Ferguson CW; Chima RS; Desser TS; Morimoto LN; Kamaya A Abdom Radiol (NY); 2021 Nov; 46(11):5134-5141. PubMed ID: 34228197 [TBL] [Abstract][Full Text] [Related]
31. Associations of Ultrasound LI-RADS Visualization Score With Examination, Sonographer, and Radiologist Factors: Retrospective Assessment in Over 10,000 Examinations. Fetzer DT; Browning T; Xi Y; Yokoo T; Singal AG AJR Am J Roentgenol; 2022 Jun; 218(6):1010-1020. PubMed ID: 34910539 [No Abstract] [Full Text] [Related]
32. Contrast-enhanced US with Sulfur Hexafluoride and Perfluorobutane: LI-RADS for Diagnosing Hepatocellular Carcinoma. Li L; Zou X; Zheng W; Li Y; Xu X; Li K; Su Z; Han J; Li Q; Zuo Y; Xie S; Wen H; Wang J; Guo Z; Zou R; Zhou J Radiology; 2023 Aug; 308(2):e230150. PubMed ID: 37642573 [TBL] [Abstract][Full Text] [Related]
33. Diagnostic efficacy of contrast-enhanced ultrasound versus MRI Liver Imaging Reporting and Data System (LI-RADS) for categorising hepatic observations in patients at risk of hepatocellular carcinoma. Li S; Zhou L; Chen R; Chen Y; Niu Z; Qian L; Fang Y; Xu L; Xu H; Zhang L Clin Radiol; 2021 Feb; 76(2):161.e1-161.e10. PubMed ID: 33198943 [TBL] [Abstract][Full Text] [Related]
34. Outcomes of LI-RADS US-2 Subthreshold Observations Detected on Surveillance Ultrasound. Tse JR; Shen L; Bird KN; Yoon L; Kamaya A AJR Am J Roentgenol; 2022 Nov; 219(5):774-783. PubMed ID: 35703411 [No Abstract] [Full Text] [Related]
35. Ultrasound LI-RADS Visualization Scores on Surveillance Ultrasound for Hepatocellular Carcinoma: A Systematic Review With Meta-analysis. Kang JH; Kim NH; Kim DH; Choi Y; Choi JI Ultrasound Med Biol; 2023 Oct; 49(10):2205-2212. PubMed ID: 37517886 [TBL] [Abstract][Full Text] [Related]
36. Evaluation of LI-RADS Version 2018 Treatment Response Algorithm for Hepatocellular Carcinoma in Liver Transplant Candidates: Intraindividual Comparison between CT and Hepatobiliary Agent-enhanced MRI. Bae JS; Lee JM; Yoon JH; Kang HJ; Jeon SK; Joo I; Lee KB; Kim H Radiology; 2021 May; 299(2):336-345. PubMed ID: 33650901 [TBL] [Abstract][Full Text] [Related]
37. Liver imaging: it is time to adopt standardized terminology. Chernyak V; Tang A; Do RKG; Kamaya A; Kono Y; Santillan CS; Fowler KJ; Bashir MR; Cunha GM; Fetzer DT; Kielar A; Lee JT; Mendiratta-Lalla M; Sirlin CB; Eur Radiol; 2022 Sep; 32(9):6291-6301. PubMed ID: 35389052 [TBL] [Abstract][Full Text] [Related]
38. Diagnostic efficacy of the Liver Imaging-Reporting and Data System (LI-RADS) with CT imaging in categorising small nodules (10-20 mm) detected in the cirrhotic liver at screening ultrasound. Abd Alkhalik Basha M; Abd El Aziz El Sammak D; El Sammak AA Clin Radiol; 2017 Oct; 72(10):901.e1-901.e11. PubMed ID: 28673446 [TBL] [Abstract][Full Text] [Related]
39. Introduction to the Liver Imaging Reporting and Data System for Hepatocellular Carcinoma. Tang A; Singal AG; Mitchell DG; Hecht EM; Fowler KJ; Kulik L; Parikh ND; Kono Y; Sirlin CB Clin Gastroenterol Hepatol; 2019 Jun; 17(7):1228-1238. PubMed ID: 30326302 [TBL] [Abstract][Full Text] [Related]